These observations indicate that TIM‐3 RNA expression is heterogeneous, but more common in pancreatic cancer and in tumors exploiting PD‐L1 and CTLA‐4 checkpoints. This evidence concerns the gene HAVCR2 and familial pancreatic carcinoma.